Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
glutathione-S-transferase + 7,8-diacetoxy-4-methylcoumarin
?
glutathione-S-transferase + acetyl-CoA
?
palmitoyl-CoA + adenylate cyclase toxin
CoA + palmitoyladenylate cyclase toxin
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
RGS16 + palmitoyl-CoA
O-palmitoyl-RGS16 + CoA
-
RGS16 is the regulator of G protein signaling 16
-
-
r
tubulin Galphai + palmitoyl-CoA
O-palmitoyl-tubulin Galphai + CoA
-
-
-
-
r
additional information
?
-
glutathione-S-transferase + 7,8-diacetoxy-4-methylcoumarin
?
-
-
-
-
?
glutathione-S-transferase + 7,8-diacetoxy-4-methylcoumarin
?
-
-
-
-
?
glutathione-S-transferase + acetyl-CoA
?
-
recombinant Schistosoma japonicum glutathione S-transferase
-
-
?
glutathione-S-transferase + acetyl-CoA
?
-
-
-
-
?
palmitoyl-CoA + adenylate cyclase toxin
CoA + palmitoyladenylate cyclase toxin
-
acyltransferase CyaC palmitoylates the conserved lysines 983 and 860 of adenylate cyclase toxin
-
?
palmitoyl-CoA + adenylate cyclase toxin
CoA + palmitoyladenylate cyclase toxin
-
palmitoylation activates adenylate cyclase toxin
-
?
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
involved in modification of membrane glycoproteins
-
?
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
-
-
?
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
involved in modification of membrane glycoproteins
-
?
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
-
-
?
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
involved in modification of membrane glycoproteins
-
?
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
protein S-palmitoylation is a posttranslational modification in which a palmitoyl group is added to a protein via a thioester linkage on cysteine
-
-
r
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
purified recombinant His6:Erf2-Erf4 complex
-
-
r
additional information
?
-
-
protein acyltransferase function of purified calreticulin. The rhCRTAase/P-domain also undergoes autoacylation by acyloxycoumarins. The isolated autoacylated rhCRTAase/P-domain in non-denatured form alone exhibits the ability to transfer acyl group to rGST indicating the stable intermediate nature of the acylated enzyme
-
-
?
additional information
?
-
-
P-domain catalyzed acetylation of rGST by 7,8-diacetoxy-4-methylcoumarin or acetyl-CoA results in the modification of several lysine residues, LC-MS/MS analysis. Residues Lys173 and Lys174 are present in the P-domain, and are responsible for binding of acyloxycoumarins and acetyl-CoA, they are probably part of the active site
-
-
?
additional information
?
-
-
histone H4 protein is subject to palmitoylation catalyzed by Lpcat1 in a calcium-regulated manner. Cytosolic Lpcat1 shifts into the nucleus in lung epithelia in response to exogenous Ca2+. Nuclear Lpcat1 colocalizes with and binds to histone H4, where it catalyzes histone H4 palmitoylation. Residue Ser47 within histone H4 serves as a putative acceptor site, indicative of Lpcat1-mediated O-palmitoylation. Lpcat1 knock-down or expression of a histone H4 Ser47A mutant protein in cells decreases cellular mRNA synthesis
-
-
?
additional information
?
-
-
besides glutamine synthetase activity, recombinant glutamine synthetase, GlnA1, of Mycobacterium tuberculosis shows additional MTAase function. MTAase exhibits differential specificities to several acyloxycoumarins, and is also capable of transferring propionyl and butyryl groups from propoxy and butoxy derivatives of 4-methylcoumarin, detailed overview. MTAase fails to accept as substrates the compounds bearing acetoxy group on the lactone ring at C-3/C-4 position of coumarin
-
-
?
additional information
?
-
-
acylation of proteins through the addition of palmitate to a cysteine residue is a common posttranslational modification for a variety of proteins
-
-
?
additional information
?
-
-
the enzyme shows a preference for palmitate and to a lesser degree for other long-chain fatty acids, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
glutathione-S-transferase + 7,8-diacetoxy-4-methylcoumarin
?
-
-
-
-
?
palmitoyl-CoA + adenylate cyclase toxin
CoA + palmitoyladenylate cyclase toxin
-
palmitoylation activates adenylate cyclase toxin
-
?
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
additional information
?
-
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
involved in modification of membrane glycoproteins
-
?
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
involved in modification of membrane glycoproteins
-
?
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
involved in modification of membrane glycoproteins
-
?
palmitoyl-CoA + mucus glycoprotein
CoA + O-palmitoylglycoprotein
-
protein S-palmitoylation is a posttranslational modification in which a palmitoyl group is added to a protein via a thioester linkage on cysteine
-
-
r
additional information
?
-
-
protein acyltransferase function of purified calreticulin. The rhCRTAase/P-domain also undergoes autoacylation by acyloxycoumarins. The isolated autoacylated rhCRTAase/P-domain in non-denatured form alone exhibits the ability to transfer acyl group to rGST indicating the stable intermediate nature of the acylated enzyme
-
-
?
additional information
?
-
-
histone H4 protein is subject to palmitoylation catalyzed by Lpcat1 in a calcium-regulated manner. Cytosolic Lpcat1 shifts into the nucleus in lung epithelia in response to exogenous Ca2+. Nuclear Lpcat1 colocalizes with and binds to histone H4, where it catalyzes histone H4 palmitoylation. Residue Ser47 within histone H4 serves as a putative acceptor site, indicative of Lpcat1-mediated O-palmitoylation. Lpcat1 knock-down or expression of a histone H4 Ser47A mutant protein in cells decreases cellular mRNA synthesis
-
-
?
additional information
?
-
-
besides glutamine synthetase activity, recombinant glutamine synthetase, GlnA1, of Mycobacterium tuberculosis shows additional MTAase function. MTAase exhibits differential specificities to several acyloxycoumarins, and is also capable of transferring propionyl and butyryl groups from propoxy and butoxy derivatives of 4-methylcoumarin, detailed overview. MTAase fails to accept as substrates the compounds bearing acetoxy group on the lactone ring at C-3/C-4 position of coumarin
-
-
?
additional information
?
-
-
acylation of proteins through the addition of palmitate to a cysteine residue is a common posttranslational modification for a variety of proteins
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Adenocarcinoma
Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci.
Adenocarcinoma
Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
Adenocarcinoma
Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors.
Adenocarcinoma of Lung
LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Asthma
Lentiviral vector-mediated delivery of lysophosphatidylcholine acyltransferase 1 attenuates airway inflammation in ovalbumin-induced allergic asthmatic mice.
Autoimmune Diseases
p300 protein acetyltransferase activity suppresses systemic lupus erythematosus-like autoimmune disease in mice.
Blindness
Loss of lysophosphatidylcholine acyltransferase 1 leads to photoreceptor degeneration in rd11 mice.
Brain Neoplasms
LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Breast Neoplasms
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence.
Breast Neoplasms
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
Carcinogenesis
Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression confers aggressiveness and independently predicts recurrence in bladder urothelial carcinomas.
Carcinoma
Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression confers aggressiveness and independently predicts recurrence in bladder urothelial carcinomas.
Carcinoma
Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
Carcinoma
LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
Carcinoma
LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma.
Carcinoma
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence.
Carcinoma, Ductal
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence.
Carcinoma, Hepatocellular
LPCAT1 overexpression promotes the progression of hepatocellular carcinoma.
Carcinoma, Hepatocellular
LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1.
Carcinoma, Hepatocellular
Patt1, a novel protein acetyltransferase that is highly expressed in liver and downregulated in hepatocellular carcinoma, enhances apoptosis of hepatoma cells.
Carcinoma, Intraductal, Noninfiltrating
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence.
Carcinoma, Lobular
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
Carcinoma, Squamous Cell
Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
Carcinoma, Squamous Cell
LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
Colonic Neoplasms
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer.
Diabetes Mellitus, Type 2
A Regulatory Role of LPCAT1 in the Synthesis of Inflammatory Lipids, PAF and LPC, in the Retina of Diabetic Mice.
Diabetic Retinopathy
A Regulatory Role of LPCAT1 in the Synthesis of Inflammatory Lipids, PAF and LPC, in the Retina of Diabetic Mice.
Endometrial Neoplasms
Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer.
Esophageal Neoplasms
Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
Esophageal Neoplasms
Leukocyte-Mediated Combined Targeted Chemo and Gene Therapy for Esophageal Cancer.
Esophageal Squamous Cell Carcinoma
LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma.
glycoprotein o-fatty-acyltransferase deficiency
Methylthioadenosine phosphorylase deficiency in acute leukemia: pathologic, cytogenetic, and clinical features.
glycoprotein o-fatty-acyltransferase deficiency
Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors.
Hyperlipidemias
Modulation of Lipid Metabolism by Celastrol.
Infections
Lysophosphatidylcholine acyltransferase 1 is downregulated by hepatitis C virus: impact on production of lipo-viro-particles.
Leber Congenital Amaurosis
Loss of lysophosphatidylcholine acyltransferase 1 leads to photoreceptor degeneration in rd11 mice.
Leukemia
Methylthioadenosine phosphorylase deficiency in acute leukemia: pathologic, cytogenetic, and clinical features.
Leukemia
Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors.
Leukemia, Myeloid, Acute
Identification of LPCAT1 expression as a potential prognostic biomarker guiding treatment choice in acute myeloid leukemia.
Leukemia, Myeloid, Acute
Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors.
Liver Cirrhosis
Chemical profile of Swertia mussotii Franch and its potential targets against liver fibrosis revealed by cross-platform metabolomics.
Lung Neoplasms
Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci.
Lung Neoplasms
Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors.
Lymphatic Metastasis
Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Melanoma
Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors.
Mouth Neoplasms
Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Neoplasm Metastasis
Leukocyte-Mediated Combined Targeted Chemo and Gene Therapy for Esophageal Cancer.
Neoplasm Metastasis
LPCAT1 overexpression promotes the progression of hepatocellular carcinoma.
Neoplasm Metastasis
LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Neoplasm Metastasis
LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
Neoplasm Metastasis
LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1.
Neoplasm Metastasis
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence.
Neoplasm Metastasis
Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Neoplasms
A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers.
Neoplasms
Diagnostic marker signature for esophageal cancer from transcriptome analysis.
Neoplasms
Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression confers aggressiveness and independently predicts recurrence in bladder urothelial carcinomas.
Neoplasms
Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer.
Neoplasms
High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.
Neoplasms
Identification of LPCAT1 expression as a potential prognostic biomarker guiding treatment choice in acute myeloid leukemia.
Neoplasms
Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
Neoplasms
LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
Neoplasms
LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Neoplasms
LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
Neoplasms
LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1.
Neoplasms
LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma.
Neoplasms
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer.
Neoplasms
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence.
Neoplasms
Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Neoplasms
Membrane Lipid Remodeling Takes Center Stage in Growth Factor Receptor-Driven Cancer Development.
Neoplasms
Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors.
Neoplasms
Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling.
Neoplasms
The protein acetyltransferase ARD1: a novel cancer drug target?
Neoplasms
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
Neuralgia
Relief from neuropathic pain by blocking of the platelet-activating factor-pain loop.
Pancreatic Neoplasms
Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis.
Pneumonia
C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.
Polycystic Ovary Syndrome
Methylome and transcriptome profiling revealed epigenetic silencing of LPCAT1 and PCYT1A associated with lipidome alterations in polycystic ovary syndrome.
Prostatic Neoplasms
Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers.
Prostatic Neoplasms
Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways.
Prostatic Neoplasms
High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.
Prostatic Neoplasms
LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
Respiratory Distress Syndrome
Gene variants of the phosphatidylcholine synthesis pathway do not contribute to RDS in the Chinese population.
Respiratory Distress Syndrome, Newborn
Genetic Polymorphisms of LPCAT1, CHPT1 and PCYT1B and Risk of Neonatal Respiratory Distress Syndrome among a Chinese Han Population.
Retinal Degeneration
Effects of Subretinal Gene Transfer at Different Time Points in a Mouse Model of Retinal Degeneration.
Retinal Degeneration
Molecular screening of the LPCAT1 gene in patients with retinitis pigmentosa without defined mutations in known retinitis pigmentosa genes.
Retinal Diseases
Temporal ChIP-on-Chip of RNA-Polymerase-II to detect novel gene activation events during photoreceptor maturation.
Retinitis Pigmentosa
Loss of lysophosphatidylcholine acyltransferase 1 leads to photoreceptor degeneration in rd11 mice.
Retinitis Pigmentosa
Molecular screening of the LPCAT1 gene in patients with retinitis pigmentosa without defined mutations in known retinitis pigmentosa genes.
Sepsis
LPS impairs phospholipid synthesis by triggering beta-transducin repeat-containing protein (beta-TrCP)-mediated polyubiquitination and degradation of the surfactant enzyme acyl-CoA:lysophosphatidylcholine acyltransferase I (LPCAT1).
Tuberculosis
Acetylation of acetyl-CoA synthetase from Mycobacterium tuberculosis leads to specific inactivation of the adenylation reaction.
Tuberculosis
Characterization of protein acyltransferase function of recombinant purified GlnA1 from Mycobacterium tuberculosis: A moon lighting property.
Tuberculosis
Novel protein acetyltransferase, Rv2170, modulates carbon and energy metabolism in Mycobacterium tuberculosis.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Kasinathan, C.; Grzelinska, E.; Okazaki, K.; Slomiany, B.L.; Slomiany, A.
Purification of protein fatty acyltransferase and determination of its distribution and topology
J. Biol. Chem.
265
5139-5144
1990
Rattus norvegicus, Rattus norvegicus Sprague-Dawley
brenda
Schmidt, M.F.G.; Burns, G.R.
Solubilization of protein fatty acyltransferase from placental membranes and cell-free acyl transfer on to exogenous and endogenous acceptors
Biochem. Soc. Trans.
17
859-861
1989
Homo sapiens
brenda
Basar, T.; Havlicek, V.; Bezouskova, S.; Hackett, M.; Sebo, P.
Acylation of lysine 983 is sufficient for toxin activity of Bordetella pertussis adenylate cyclase. Substitutions of alanine 140 modulate acylation site selectivity of the toxin acyltransferase CyaC
J. Biol. Chem.
276
348-354
2001
Bordetella pertussis
brenda
Micchelli, C.A.; The, I.; Selva, E.; Mogila, V.; Perrimon, N.
Rasp, a putative transmembrane acyltransferase, is required for Hedgehog signaling
Development
129
843-851
2002
Drosophila melanogaster
brenda
Hiol, A.; Caron, J.M.; Smith, C.D.; Jones, T.L.
Characterization and partial purification of protein fatty acyltransferase activity from rat liver
Biochim. Biophys. Acta
1635
10-19
2003
Rattus norvegicus
brenda
Zou, C.; Ellis, B.M.; Smith, R.M.; Chen, B.B.; Zhao, Y.; Mallampalli, R.K.
Acyl-CoA:lysophosphatidylcholine acyltransferase I (Lpcat1) catalyzes histone protein O-palmitoylation to regulate mRNA synthesis
J. Biol. Chem.
286
28019-28025
2011
Mus musculus
brenda
Mitchell, D.A.; Hamel, L.D.; Ishizuka, K.; Mitchell, G.; Schaefer, L.M.; Deschenes, R.J.
The erf4 subunit of the yeast ras palmitoyl acyltransferase is required for stability of the acyl-erf2 intermediate and palmitoyl transfer to a ras2 substrate
J. Biol. Chem.
287
34337-34348
2012
Saccharomyces cerevisiae
brenda
Baghel, A.S.; Tandon, R.; Gupta, G.; Kumar, A.; Sharma, R.K.; Aggarwal, N.; Kathuria, A.; Saini, N.K.; Bose, M.; Prasad, A.K.; Sharma, S.K.; Nath, M.; Parmar, V.S.; Raj, H.G.
Characterization of protein acyltransferase function of recombinant purified GlnA1 from Mycobacterium tuberculosis: a moon lighting property
Microbiol. Res.
166
662-672
2011
Mycobacterium tuberculosis
brenda
Singh, P.; Ponnan, P.; Priya, N.; Tyagi, T.K.; Gaspari, M.; Krishnan, S.; Cuda, G.; Joshi, P.; Gambhir, J.K.; Sharma, S.K.; Prasad, A.K.; Saso, L.; Rastogi, R.C.; Parmar, V.S.; Raj, H.G.
Protein acyltransferase function of purified calreticulin: the exclusive role of P-domain in mediating protein acylation utilizing acyloxycoumarins and acetyl CoA as the acyl group donors
Protein Pept. Lett.
18
507-517
2011
Haemonchus contortus
brenda